Sponsored by:

Duke MMIL designs novel SPECT/CT system for 3D breast imaging

Jul 17, 2007
2007 07 17 14 38 39 706
2007 07 17 14 38 39 706
Image courtesy of Duke University Medical Center Multi-Modality Imaging Lab.

close

Latest in Molecular Imaging
Heart
PiB-PET/CT detects subtypes in cardiac amyloidosis
December 5, 2025
Snmmi
SNMMI notes pros and cons in CMS final 2026 OPPS rule
November 26, 2025
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsored
Expand your field of view with new Biograph Trinion.X PET/CT
November 13, 2025
Money Bills Sky Line
ConcertAI launches new reimbursement tool
November 21, 2025
Related Stories
2007 07 17 15 08 50 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 07 17 14 32 28 706
Molecular Imaging
Duke MMIL designs novel SPECT/CT system for 3D breast imaging
2007 06 25 10 54 15 706
Molecular Imaging
Studies link Alzheimer's to beta-amyloid and potential for new ligand
Expand your field of view with new Biograph Trinion.X PET/CT
Sponsor Content
Expand your field of view with new Biograph Trinion.X PET/CT
More in Molecular Imaging
PiB-PET/CT detects subtypes in cardiac amyloidosis
By Will Morton
PiB-PET/CT shows strong promise as a next-generation diagnostic tool for cardiac amyloidosis.
December 5, 2025
Heart
SNMMI notes pros and cons in CMS final 2026 OPPS rule
By AuntMinnie.com staff writers
The final rule includes two new Healthcare Common Procedure Coding System (HCPCS) codes relevant to nuclear medicine.
November 26, 2025
Snmmi
New SPECT/CT tracer visualizes distribution of ALS drug
By Will Morton
Tofersen has been approved for treating amyotrophic lateral sclerosis (ALS), but its regional brain uptake is not fully understood.
November 25, 2025
SPECT imaging of Tc-99m MAG3-tofersen in healthy human volunteers. (A) Maximum-intensity-projection images showing distribution of Tc-99m MAG3-tofersen in humans (n = 3) one, four, and 24 hours after intrathecal injection. Time–activity curves derived from SPECT data measuring activity in ROIs in CNS (lumbar, thoracic, and cervical spine ROIs include both cord and proximal CSF) (B), kidneys and liver (C), and brain atlas (D).
ConcertAI launches new reimbursement tool
By AuntMinnie.com staff writers
AI-powered platform tailored to payer requirements for reimbursable imaging biomarkers.
November 21, 2025
Money Bills Sky Line
UCLA to launch department of nuclear medicine and theranostics
By AuntMinnie.com staff writers
The University of California, Los Angeles (UCLA) will open a department of nuclear medicine and theranostics on January 1, 2026.
November 19, 2025
Nuclearmedicine
Cardiology network extends adoption of GEHC's Flyrcado
By AuntMinnie.com staff writers
After a successful pilot, Cardiovascular Associates of America plans to expand adoption of GEHC's radiotracer Flyrcado.
November 19, 2025
Pet Scanner Bore 400
Stress coping may protect against cognitive decline
By Will Morton
Adaptive coping was associated with better cognitive trajectories, independent of amyloid and tau PET brain pathology.
November 18, 2025
Ad
Siemens Healthineers rebrands radiopharmaceutical companies
By AuntMinnie.com staff writers
Siemens Healthineers has rebranded PETNet Solutions and AdAcAp Molecular Imaging as its radiopharma business segment.
November 18, 2025
Siemens Rsna 2021 400
ITM secures U.S. FDA fast-track designation for kidney cancer PET agent
By AuntMinnie.com staff writers
Along with the radiotherapeutic compound ITM-91, the two make up a peptide-based theranostic pair.
November 17, 2025
Atom Molecule
IAEA recommends global adoption of PSMA-PET
By Will Morton
The finding follows a trial involving 775 men with high-risk prostate cancer across 11 countries with varied income levels.
November 14, 2025
2025 11 14 Iaea Recommends Psma Pet Thumbnail
SNMMI issues position paper on RPT
By AuntMinnie.com staff writers
Radiopharmaceutical therapy (RPT) is a rapidly growing form of precision cancer treatment.
November 12, 2025
Snmmi
PSMA-PET effective for initial staging of prostate cancer
By Will Morton
Upfront PSMA-PET/CT has a significant impact on treatment decision-making in men with suspected disease.
November 10, 2025
2025 11 10 Psma Pet Phase Ii Trial Thumbnail
Page 1 of 617
Next Page